Ambev (NYSE:ABEV - Get Free Report) issued its quarterly earnings results on Tuesday. The company reported $0.05 earnings per share for the quarter, meeting analysts' consensus estimates of $0.05, FiscalAI reports. Ambev had a net margin of 17.75% and a return on equity of 16.41%. The company had revenue of $4.32 billion during the quarter, compared to the consensus estimate of $4.36 billion.
Ambev Price Performance
NYSE ABEV opened at $2.91 on Tuesday. The stock's 50-day moving average price is $2.98 and its two-hundred day moving average price is $2.71. The company has a current ratio of 0.96, a quick ratio of 0.73 and a debt-to-equity ratio of 0.03. The company has a market cap of $45.79 billion, a PE ratio of 16.14, a PEG ratio of 2.08 and a beta of 0.61. Ambev has a 1 year low of $2.10 and a 1 year high of $3.24.
Insider Transactions at Ambev
In other Ambev news, insider De Lacerda Eduardo Cavalcanti sold 152,386 shares of the business's stock in a transaction dated Friday, March 27th. The stock was sold at an average price of $2.85, for a total transaction of $434,300.10. Following the sale, the insider owned 223,340 shares in the company, valued at approximately $636,519. The trade was a 40.56% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Institutional Trading of Ambev
Several institutional investors and hedge funds have recently bought and sold shares of the stock. Marex Group plc purchased a new position in shares of Ambev during the second quarter valued at $48,000. Principal Securities Inc. increased its holdings in Ambev by 46.4% in the fourth quarter. Principal Securities Inc. now owns 19,593 shares of the company's stock worth $48,000 after buying an additional 6,208 shares during the last quarter. HRT Financial LP acquired a new position in Ambev in the fourth quarter worth approximately $38,000. UMB Bank n.a. increased its holdings in Ambev by 197.1% in the fourth quarter. UMB Bank n.a. now owns 14,847 shares of the company's stock worth $37,000 after buying an additional 9,850 shares during the last quarter. Finally, NorthRock Partners LLC acquired a new position in Ambev in the third quarter worth approximately $34,000. Institutional investors and hedge funds own 8.13% of the company's stock.
Wall Street Analyst Weigh In
A number of equities research analysts have weighed in on ABEV shares. Wall Street Zen downgraded shares of Ambev from a "buy" rating to a "hold" rating in a report on Monday, March 30th. UBS Group set a $2.65 price target on shares of Ambev and gave the company a "sell" rating in a report on Thursday, April 16th. Barclays upped their price target on shares of Ambev from $2.50 to $3.00 and gave the company an "equal weight" rating in a report on Tuesday, February 17th. Finally, Weiss Ratings raised shares of Ambev from a "hold (c+)" rating to a "buy (b-)" rating in a report on Thursday, March 5th. One analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, Ambev currently has an average rating of "Hold" and an average price target of $2.84.
Read Our Latest Report on Ambev
About Ambev
(
Get Free Report)
Ambev NYSE: ABEV is a Brazilian-based beverage company that produces, distributes and markets a broad portfolio of alcoholic and non-alcoholic drinks. The company's core business centers on brewing and selling beer, alongside a range of soft drinks, bottled water, energy drinks and other malt-based beverages. Headquartered in São Paulo, Ambev operates an integrated value chain that covers manufacturing, packaging, logistics and commercial sales to retail, on-premise and institutional customers.
The company traces its origins to the 1999 merger of two historic Brazilian breweries, and later became part of the broader global brewing group through subsequent industry consolidations.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ambev, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ambev wasn't on the list.
While Ambev currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.